AS Latvijas Juras medicinas centrs (RSE: LJM1R)
6.65
+0.15 (2.31%)
At close: Jan 27, 2025
RSE:LJM1R Revenue
AS Latvijas Juras medicinas centrs had revenue of 2.57M EUR in the quarter ending September 30, 2024, a decrease of -1.32%. This brings the company's revenue in the last twelve months to 10.20M, up 6.02% year-over-year. In the year 2023, AS Latvijas Juras medicinas centrs had annual revenue of 9.85M with 1.54% growth.
Revenue (ttm)
10.20M
Revenue Growth
+6.02%
P/S Ratio
n/a
Revenue / Employee
27.86K
Employees
366
Market Cap
5.20M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 9.85M | 149.86K | 1.54% |
Dec 31, 2022 | 9.70M | 337.05K | 3.60% |
Dec 31, 2021 | 9.36M | 2.28M | 32.24% |
Dec 31, 2020 | 7.08M | -190.53K | -2.62% |
Dec 31, 2019 | 7.27M | 597.58K | 8.95% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AS Amber Latvijas balzams | 85.07M |
AS Virsi-A | 366.68M |
IPAS Indexo AS | 4.08M |
DelfinGroup AS | 35.39M |
AS MADARA Cosmetics | 21.16M |
AS APF Holdings | 13.21M |
SAF Tehnika | 30.24M |
AS Siguldas Ciltslietu Un Maksligas Apseklosanas Stacija | 1.62M |